drugset / Trial / NCT03855826
Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
RandomizedParallel-groupOpen-labelTreatment
Summary
Efficacy and safety evaluation of amiodarone and Nifekalant hydrochloride(NIF) for the treatment of ventricular tachycardia and ventricular fibrillation.
Timeline
- Start
- 2019-01-15
- Primary completion
- 2020-01-30
- Completion
- 2020-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amiodarone | Small molecule | — | Intravenous |
| Subject | Nifekalant | Small molecule | 50 mg | Intravenous |